By combining a nationwide population-based cohort with experimental evidence, the PDE5 inhibitor sildenafil has been repurposed as a therapeutic agent to prevent tumor growth by suppressing c-MYC stability for IL-6 transcription in gastric cancer.
- Zhenzhan Zhang
- Wuqing Huang
- Hao Liu
